Fred C G J Sweep

Author PubWeight™ 152.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol 2006 2.48
2 Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008 2.41
3 Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 2010 2.38
4 Molecular profiling of platinum resistant ovarian cancer. Int J Cancer 2006 2.37
5 Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer. J Natl Cancer Inst 2014 2.37
6 Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma. Eur J Endocrinol 2014 2.13
7 High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome. J Clin Endocrinol Metab 2008 1.77
8 Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol 2007 1.70
9 The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy. Breast Cancer Res Treat 2008 1.68
10 Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem 2010 1.68
11 Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005 1.66
12 Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res 2008 1.57
13 Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time. J Clin Oncol 2004 1.55
14 The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey. Gynecol Oncol 2005 1.49
15 Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 2005 1.48
16 Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients. J Clin Endocrinol Metab 2008 1.36
17 Survivin is an independent prognostic marker for risk stratification of breast cancer patients. Clin Chem 2004 1.36
18 Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clin Infect Dis 2007 1.34
19 Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response. Breast Cancer Res 2013 1.33
20 Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertil Steril 2006 1.31
21 Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated? Endocr Relat Cancer 2009 1.30
22 Banking of biological fluids for studies of disease-associated protein biomarkers. Mol Cell Proteomics 2008 1.27
23 Molecular aspects of tumour hypoxia. Mol Oncol 2008 1.27
24 TRPM7 is required for breast tumor cell metastasis. Cancer Res 2012 1.27
25 Maternal behavior predicts infant cortisol recovery from a mild everyday stressor. J Child Psychol Psychiatry 2008 1.26
26 Atrial natriuretic peptide induces postprandial lipid oxidation in humans. Diabetes 2008 1.25
27 Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue. J Clin Endocrinol Metab 2007 1.16
28 Inactivating PAPSS2 mutations in a patient with premature pubarche. N Engl J Med 2009 1.15
29 A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet 2013 1.12
30 Repeated successful induction of fertility after replacing hydrocortisone with dexamethasone in a patient with congenital adrenal hyperplasia and testicular adrenal rest tumors. Fertil Steril 2007 1.11
31 Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer. Eur J Cancer 2005 1.10
32 Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding. Am J Pathol 2007 1.10
33 Secondary ovarian malignancies: frequency, origin, and characteristics. Int J Gynecol Cancer 2009 1.09
34 Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia can cause severe testicular damage. Fertil Steril 2007 1.08
35 Haematopoietic stem cells and endothelial progenitor cells in healthy men: effect of aging and training. Aging Cell 2006 1.07
36 Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease. Liver Int 2009 1.05
37 A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease. FASEB J 2011 1.05
38 Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. Clin Cancer Res 2003 1.04
39 The prognostic value of BCAR1 in patients with primary breast cancer. Clin Cancer Res 2004 1.04
40 Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer. Radiother Oncol 2011 1.02
41 Identifying estrogen receptor target genes. Mol Oncol 2007 1.01
42 Review of the role of the plasminogen activator system and vascular endothelial growth factor in subfertility. Fertil Steril 2008 1.01
43 Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response. Breast Cancer Res 2011 0.99
44 Seasonal variation in vitamin D₃ levels is paralleled by changes in the peripheral blood human T cell compartment. PLoS One 2012 0.97
45 Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma. Mol Cancer Res 2008 0.96
46 MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis. Cytokine 2006 0.96
47 ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma. Int J Cancer 2006 0.95
48 Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus. J Am Soc Nephrol 2003 0.95
49 Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients. J Clin Endocrinol Metab 2006 0.95
50 Aldo-keto reductase family 1 member C3 (AKR1C3) is a biomarker and therapeutic target for castration-resistant prostate cancer. Mol Med 2013 0.95
51 Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP). Biochim Biophys Acta 2013 0.95
52 Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer. Cancer Lett 2005 0.94
53 Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses. Arthritis Res Ther 2010 0.94
54 The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients. Pharmacogenomics 2011 0.93
55 Diffusion-weighted MR imaging in liver metastases of colorectal cancer: reproducibility and biological validation. Eur Radiol 2012 0.92
56 Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients. Biol Chem 2012 0.92
57 Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones. Cell Tissue Res 2012 0.92
58 Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors. J Cancer Res Clin Oncol 2009 0.91
59 Spuriously high free thyroxine values in familial dysalbuminemic hyperthyroxinemia. Clin Chem 2010 0.91
60 Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation. Am J Physiol Endocrinol Metab 2005 0.91
61 Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma. Clin Cancer Res 2013 0.90
62 Imaging liver metastases of colorectal cancer patients with radiolabelled bevacizumab: Lack of correlation with VEGF-A expression. Eur J Cancer 2008 0.90
63 Generation of multicellular tumor spheroids of breast cancer cells: how to go three-dimensional. Anal Biochem 2013 0.90
64 Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. Int J Mol Med 2008 0.89
65 Development of a sensitive ELISA for the quantification of human tumour necrosis factor-alpha using 4 polyclonal antibodies. Eur Cytokine Netw 2005 0.89
66 Endocrine disruptors differentially target ATP-binding cassette transporters in the blood-testis barrier and affect Leydig cell testosterone secretion in vitro. Toxicol Sci 2013 0.89
67 Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer. Cancer 2011 0.89
68 The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer. Eur J Clin Invest 2010 0.89
69 Metalloproteinases and their regulators in colorectal cancer. J Surg Oncol 2010 0.89
70 Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer. Biol Chem 2010 0.88
71 The PERK/ATF4/LAMP3-arm of the unfolded protein response affects radioresistance by interfering with the DNA damage response. Radiother Oncol 2013 0.88
72 TRIB3 protein denotes a good prognosis in breast cancer patients and is associated with hypoxia sensitivity. Radiother Oncol 2011 0.87
73 Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation. Biochim Biophys Acta 2009 0.87
74 αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma. BMC Cancer 2013 0.87
75 FSH isoform pattern in classic galactosemia. J Inherit Metab Dis 2010 0.87
76 Impaired vascular responses to relaxin in diet-induced overweight female rats. J Appl Physiol (1985) 2011 0.86
77 Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer? Clin Chem 2006 0.86
78 Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells. Cancer Res 2007 0.86
79 Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma. Ann Clin Biochem 2012 0.86
80 Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues. BJU Int 2008 0.86
81 LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy. Endocr Relat Cancer 2014 0.86
82 European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology Group standard operating procedure for the preparation of human tumour tissue extracts suited for the quantitative analysis of tissue-associated biomarkers. Eur J Cancer 2007 0.86
83 Regulation of TRIB3 mRNA and protein in breast cancer. PLoS One 2012 0.85
84 Kinetics of myo-inositol loading in women of reproductive age. Ann Clin Biochem 2003 0.85
85 Plasma metanephrine for assessing the selectivity of adrenal venous sampling. Hypertension 2013 0.85
86 Aging attenuates the vasodilator response to relaxin. Am J Physiol Heart Circ Physiol 2011 0.85
87 Protein chip based miniaturized assay for the simultaneous quantitative monitoring of cancer biomarkers in tissue extracts. Proteomics 2006 0.84
88 Role of endogenous vascular endothelial growth factor in endothelium-dependent vasodilation in humans. Hypertension 2013 0.84
89 Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer. Int J Cancer 2008 0.84
90 Plasma metanephrines in renal failure. Kidney Int 2005 0.84
91 Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy. Eur J Obstet Gynecol Reprod Biol 2006 0.84
92 The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (review). Int J Oncol 2008 0.84
93 Increase in the incidence of gestational trophoblastic disease in The Netherlands. Gynecol Oncol 2011 0.83
94 Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infection. Cytokine 2012 0.83
95 Is there a relationship between fatigue perception and the serum levels of thyrotropin and free thyroxine in euthyroid subjects? Thyroid 2012 0.83
96 Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines. BMC Cancer 2007 0.83
97 Adult patients with congenital adrenal hyperplasia have elevated blood pressure but otherwise a normal cardiovascular risk profile. PLoS One 2011 0.83
98 High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Breast Cancer Res Treat 2006 0.83
99 Rho GDP dissociation inhibitor alpha expression correlates with the outcome of CMF treatment in invasive ductal breast cancer. Int J Oncol 2010 0.82
100 Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes. Obstet Gynecol 2012 0.82
101 Should anterior pituitary function be tested during follow-up of all patients presenting at the emergency department because of traumatic brain injury? Eur J Endocrinol 2009 0.82
102 Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer. Breast Cancer Res Treat 2012 0.82
103 Expression of the novel epithelial Ca2+ channel ECaC1 in rat pancreatic islets. J Histochem Cytochem 2002 0.82
104 Downregulation of serine protease HTRA1 is associated with poor survival in breast cancer. PLoS One 2013 0.82
105 Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer. Clin Chem 2006 0.81
106 Associations of common variants in HFE and TMPRSS6 with iron parameters are independent of serum hepcidin in a general population: a replication study. J Med Genet 2013 0.81
107 Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function. Eur J Heart Fail 2003 0.81
108 Identification, validation, and clinical implementation of tumor-associated biomarkers to improve therapy concepts, survival, and quality of life of cancer patients: tasks of the Receptor and Biomarker Group of the European Organization for Research and Treatment of Cancer. Int J Oncol 2004 0.81
109 Hypoxia regulation of phosphokinases and the prognostic value of pAKT in breast cancer. Int J Biol Markers 2013 0.81
110 Usefulness of intraoperative parathyroid hormone measurements in patients with renal hyperparathyroidism. Head Neck 2010 0.81
111 Poor prognosis of constitutive γ-H2AX expressing triple-negative breast cancers is associated with telomere length. Biomark Med 2015 0.81
112 Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases. Clin Immunol 2007 0.81
113 Liver afferents contribute to water drinking-induced sympathetic activation in human subjects: a clinical trial. PLoS One 2011 0.80
114 Impaired effect of relaxin on vasoconstrictor reactivity in spontaneous hypertensive rats. Peptides 2013 0.80
115 Serum vascular endothelial growth factor: a prognostic factor in cervical cancer. J Cancer Res Clin Oncol 2008 0.80
116 Stability of urinary fractionated metanephrines and catecholamines during collection, shipment, and storage of samples. Clin Chem 2006 0.80
117 Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis. PLoS Negl Trop Dis 2010 0.79
118 Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios. Eur J Endocrinol 2005 0.79
119 Assay bias may invalidate decision limits and affect comparability of serum thyroglobulin assay methods: an approach to reduce interpretation differences. Clin Chim Acta 2008 0.79
120 The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer. Thromb Haemost 2004 0.79
121 Effect of reoxygenation on the hypoxia-induced up-regulation of serine protease inhibitor PAI-1 in head and neck cancer cells. Oncology 2007 0.78
122 Underestimation of effect of thyroid function parameters on morbidity and mortality due to intra-individual variation. J Clin Endocrinol Metab 2011 0.78
123 Is survivin expression nevertheless related to disease outcome in breast cancer? Breast Cancer Res Treat 2006 0.78
124 Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles. Obstet Gynecol 2009 0.78
125 Transient human anti-mouse antibodies (HAMA) interference in CA 125 measurements during monitoring of ovarian cancer patients treated with murine monoclonal antibody. Gynecol Oncol 2008 0.78
126 Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands. Gynecol Oncol 2007 0.78
127 Effects of naproxen and sulphasalazine or methotrexate on hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis. Clin Exp Rheumatol 2011 0.78
128 Psychophysiological responses to stress after stress management training in patients with rheumatoid arthritis. PLoS One 2011 0.78
129 Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease. Gynecol Oncol 2010 0.78
130 Possible role of the plasminogen activation system in human subfertility. Fertil Steril 2006 0.78
131 Occurrence of postmenopausal-like acidic follicle-stimulating hormone (FSH) isoforms precedes the rise of FSH before menopause. Fertil Steril 2008 0.78
132 Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer. Oncol Rep 2010 0.77
133 Sympathetic nervous system function in HIV-associated adipose redistribution syndrome. AIDS 2006 0.77
134 Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma. Cancer 2004 0.77
135 Molecular characterization of testicular adrenal rest tumors in congenital adrenal hyperplasia: lesions with both adrenocortical and Leydig cell features. J Clin Endocrinol Metab 2014 0.77
136 Maternal soluble fms-like tyrosine kinase-1, placental growth factor, plasminogen activator inhibitor-2, and folate concentrations and early fetal size: the Generation R study. Am J Obstet Gynecol 2013 0.77
137 Tissue inhibitor metalloproteinase type-1 (TIMP-1), a novel cancer biomarker predicting response of adjuvant anthracycline-based chemotherapy in patients afflicted with primary breast cancer. Eur J Cancer 2009 0.77
138 Longitudinal trends in thyroid function in relation to iodine intake: ongoing changes of thyroid function despite adequate current iodine status. Eur J Endocrinol 2013 0.77
139 Human anti-mouse IgM and IgG responses in ovarian cancer patients after radioimmunotherapy with 90Y-muHMFG1. Anticancer Res 2008 0.77
140 Contribution of different local vascular responses to mid-gestational vasodilation. Am J Obstet Gynecol 2011 0.76
141 Effect of naproxen on the hypothalamic-pituitary-adrenal axis in healthy volunteers. Br J Clin Pharmacol 2009 0.76
142 Composite reference interval for thyroid-stimulating hormone and free thyroxine, comparison with common cutoff values, and reconsideration of subclinical thyroid disease. Clin Chem 2009 0.76
143 Exhaustion is associated with low macrophage migration inhibitory factor expression in patients with coronary artery disease. Psychosom Med 2007 0.76
144 Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients. Clin Cancer Res 2003 0.76
145 Re: p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy. J Natl Cancer Inst 2007 0.76
146 αB-crystallin expression is correlated with phospho-ERK1/2 expression in human breast cancer. Int J Biol Markers 2013 0.76
147 Co-occurrence of cardiovascular and prothrombotic risk factors in women with a history of preeclampsia. Obstet Gynecol 2013 0.76
148 Transport within the interstitial space, rather than membrane permeability, determines norepinephrine recovery in microdialysis. J Pharmacol Exp Ther 2006 0.76
149 Pitfall in HPLC assay for urinary metanephrines: an unusual type of interference caused by methenamine intake. Clin Chem 2004 0.76
150 Empathic accuracy and oxytocin after tryptophan depletion in adults at risk for depression. Psychopharmacology (Berl) 2016 0.75
151 Mammaglobin RT-qPCR for breast cancer metastasis detection in sentinel lymph nodes. Cancer Sci 2010 0.75
152 Second curettage in persistent trophoblastic disease (PTD): the need for univocal definition of PTD. Gynecol Oncol 2005 0.75
153 Mammaglobin as molecular marker of breast cancer (micro)metastases. Clin Cancer Res 2005 0.75
154 Concerns about mammaglobin assays. Clin Chem 2005 0.75
155 Centralised registration of gestational trophoblastic disease and trends in incidence. Acta Oncol 2012 0.75
156 Salivary morning androstenedione and 17α-OH progesterone levels in childhood and puberty in patients with classic congenital adrenal hyperplasia. Clin Chem Lab Med 2015 0.75
157 Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy. Int J Mol Med 2006 0.75
158 Subclinical hypothyroidism after vascular complicated pregnancy. Hypertens Pregnancy 2013 0.75
159 Dopamine susceptibility of APO-SUS rats is not per se coupled to HPA-axis activity. Physiol Behav 2010 0.75
160 Follicle-stimulating hormone isoforms are not useful as pretreatment predictors of outcome in in vitro fertilization: a pilot study. Fertil Steril 2006 0.75
161 Quantification of patient-specific assay interference in different formats of enzyme-linked immunoassays for therapeutic monoclonal antibodies. Ther Drug Monit 2014 0.75
162 A simple method for estimating equilibrium constants for serum testosterone binding resulting in an optimal free testosterone index for use in elderly men. Clin Chem Lab Med 2005 0.75
163 Single versus duplicate blood samples in ACTH stimulated adrenal vein sampling. Clin Chim Acta 2013 0.75
164 A study of longer-time stability of plasma free metanephrines. Ann Clin Biochem 2011 0.75
165 Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without decreasing VEGF expression. Mol Pharm 2014 0.75
166 Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia. Int J Gynecol Cancer 2013 0.75